Literature DB >> 16601371

Minimal change glomerulonephritis in chronic lymphocytic leukemia: pathophysiological and therapeutic aspects.

Meritxell Garcia Alzamora1, Markus Schmidli, Urs Hess, Richard Cathomas, Roger von Moos.   

Abstract

BACKGROUND: So far, only 9 cases of minimal change glomerulonephritis (MCGN) related to chronic lymphocytic leukemia (CLL) have been described. CASE REPORT: Our patient presented with severe nephrotic syndrome. Diagnostic biopsies confirmed MCGN and early-stage BCLL (Binet A). In contrast to previously described cases, kappa monoclonal IgM and cryoglobulins were also detected. The patient was treated with chlorambucil and prednisone. 3 weeks later, renal function and white blood cell (WBC) count were completely normal. DISCUSSION: Although, in most cases, renal disease and CLL present separately, there is evidence for a causal relationship between the two disorders. Although it is widely approved that early-stage CLL should not be treated by medication, the severe nephrotic syndrome in our patient required immediate intervention. So far, there is no standard therapy for MCGN associated with CLL. Our combination therapy resulted in normalization of the nephrotic syndrome and the WBC count. Hence, we emphasize the importance of early recognition of renal symptoms in CLL and propose a successful therapy for nephrotic syndrome in MCGN associated with early-stage B-CLL. Additionally, the pathophysiological and therapeutic aspects of MCGN associated with CLL are retrospectively discussed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16601371     DOI: 10.1159/000091644

Source DB:  PubMed          Journal:  Onkologie        ISSN: 0378-584X


  7 in total

1.  A rare case of atypical chronic lymphocytic leukaemia presenting as nephrotic syndrome.

Authors:  Martina Soldarini; Lucia Farina; Augusto Genderini; Niccolo Bolli
Journal:  BMJ Case Rep       Date:  2017-07-14

2.  Monoclonal B lymphocytosis and minimal change disease: a new monoclonal B-cell disorder of renal significance?

Authors:  Margaux Van Wynsberghe; Pascal Lenain; Fanny Drieux; Dominique Guerrot; Dominique Bertrand
Journal:  J Nephrol       Date:  2017-12-21       Impact factor: 3.902

3.  Chronic lymphocytic leukemia associated with immunotactoid glomerulopathy: a case report of successful treatment with high-dose methylprednisolone in combination with rituximab followed by alemtuzumab.

Authors:  Januario E Castro; Julio A Diaz-Perez; Juan S Barajas-Gamboa; John M Horton; Noel Weidner; Thomas J Kipps
Journal:  Leuk Lymphoma       Date:  2012-03-13

4.  Renal complications in chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis: the Mayo Clinic experience.

Authors:  Paolo Strati; Samih H Nasr; Nelson Leung; Curtis A Hanson; Kari G Chaffee; Susan M Schwager; Sara J Achenbach; Timothy G Call; Sameer A Parikh; Wei Ding; Neil E Kay; Tait D Shanafelt
Journal:  Haematologica       Date:  2015-06-18       Impact factor: 9.941

Review 5.  Idiopathic nephrotic syndrome: the EBV hypothesis.

Authors:  Claire Dossier; Agnès Jamin; Georges Deschênes
Journal:  Pediatr Res       Date:  2016-09-28       Impact factor: 3.756

Review 6.  Concurrent nephrotic syndrome and acute renal failure caused by chronic lymphocytic leukemia (CLL): a case report and literature review.

Authors:  Xianrui Dou; Haitang Hu; Yongle Ju; Yongdong Liu; Kaifu Kang; Shufeng Zhou; Wenfang Chen
Journal:  Diagn Pathol       Date:  2011-10-13       Impact factor: 2.644

7.  The spectrum of kidney pathology in B-cell chronic lymphocytic leukemia / small lymphocytic lymphoma: a 25-year multicenter experience.

Authors:  Anne-Laure Poitou-Verkinder; Arnaud Francois; Fanny Drieux; Stéphane Lepretre; Bruno Legallicier; Bruno Moulin; Michel Godin; Dominique Guerrot
Journal:  PLoS One       Date:  2015-03-26       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.